desf
desf: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Lead developer: Aquestive Therapeutics, Inc. (AQST)
Development Pipeline (1)
| Company | Phase |
|---|---|
| Aquestive Therapeutics, Inc. (AQST) | Phase 1 |
Clinical Trials (1)
A Phase 1, Multi-Site, Open-Label Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of DESF in Pediatric Subjects ≥30 kg With a Personal History of Allergic Reactions at High Risk for Serious Reactions (PARKS: Pediatric Anaphylm Response, Kinetics, and Safety)
Frequently asked questions
Who is developing desf?
desf is being developed by Aquestive Therapeutics, Inc..
How many clinical trials involve desf?
BioSniper tracks 1 clinical trial involving desf.
Analyze Aquestive Therapeutics, Inc. & desf with AI
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company